Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Plenary Session
General Topic: Clinical Science

13M123: Plenary II (1579–1584)

Monday, November 13, 2023
11:00 AM – 12:30 PM PT
Location: Exhibit Hall A-B
CE: 1.5

On Demand In Person Livestreamed

    Plenary Presenter(s)

  • VD

    Varun Dhir, MD, MBBS, DM

    PGIMER, CHD, INDIA
    CHANDIGARH, Chandigarh, India

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • BE

    Bryant England, MD, PhD, RhMSUS

    University of Nebraska Medical Center
    Omaha, NE, United States

    Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing)

  • MJ

    Matlock Jeffries, MD, FACP, FACR

    Oklahoma Medical Research Foundation
    Oklahoma City, OK, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • April Jorge, MD

    Massachusetts General Hospital
    Boston, MA, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • CL

    Calvin Law, PhD (he/him/his)

    Northwestern University Feinberg School of Medicine
    Chicago, IL, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

  • AM

    Arielle Mendel, MD, FRCPC, MSc

    McGill University Health Centre
    Montréal, QC, Canada

    Disclosure(s): No financial relationships with ineligible companies to disclose

Plenary abstract session.

Presentations:

  • 11:00 AM – 11:10 AM PT
    Sodium-Glucose Co-transporter-2 Inhibitors and the Risk of Cardiac and Renal Outcomes in Systemic Lupus Erythematosus

    Plenary Presenter: April Jorge, MD – Massachusetts General Hospital

  • 11:10 AM – 11:15 AM PT
    Q&A
  • 11:15 AM – 11:25 AM PT
    CXCL13+ T Cell Differentiation in Systemic Lupus Erythematosus Is Controlled by Opposing Effects of Aryl Hydrocarbon Receptor and Type I Interferon

    Plenary Presenter: Calvin Law, PhD (he/him/his) – Northwestern University Feinberg School of Medicine

  • 11:25 AM – 11:30 AM PT
    Q&A
  • 11:30 AM – 11:40 AM PT
    Microbiome Transplantation Prevents Osteoarthritis in Mice and Is Associated with Immunophenotype Changes

    Plenary Presenter: Matlock Jeffries, MD, FACP, FACR – Oklahoma Medical Research Foundation

  • 11:40 AM – 11:45 AM PT
    Q&A
  • 11:45 AM – 11:55 AM PT
    Non-TNFi b/tsDMARDs vs. TNFi in Rheumatoid Arthritis-Interstitial Lung Disease: An Active-Comparator, New-User, Propensity Score Matched Study Using National Veterans Affairs Data

    Plenary Presenter: Bryant England, MD, PhD, RhMSUS – University of Nebraska Medical Center

  • 11:55 AM – 12:00 PM PT
    Q&A
  • 12:00 PM – 12:10 PM PT
    Comparison of Two Dosing Schedules for Oral Methotrexate (Split-Dose versus Single-Dose) Once Weekly in Patients with Active Rheumatoid Arthritis: A Multicenter, Open Label, Parallel Group, Randomized Controlled Trial (SMART Study)

    Plenary Presenter: Varun Dhir, MD, MBBS, DM – PGIMER, CHD, INDIA

  • 12:10 PM – 12:15 PM PT
    Q&A
  • 12:15 PM – 12:25 PM PT
    Effect of Trimethoprim Sulfamethoxazole Prophylaxis on Infections During Treatment of Granulomatosis with Polyangiitis with Rituximab: A Population-Based Study

    Plenary Presenter: Arielle Mendel, MD, FRCPC, MSc – McGill University Health Centre

  • 12:25 PM – 12:30 PM PT
    Q&A